(Q59289818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Controlled trial of adjuvant chemotherapy with melphalan for breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

R D Rubens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

J L Hayward

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

R K Knight

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

R D Bulbrook

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

I S Fentiman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

M Chaudary

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

H Bush

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

D Crowther

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

R A Sellwood

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

W D George

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

J M Howat

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

English

0 references

publication date

1 April 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

839-843

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2991385-5

7 January 2021

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2991385-5

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2991385-5

7 January 2021

L-phenylalanine mustard (L-PAM) in the management of primary breast cancer:An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2991385-5

7 January 2021

Dose-response effect of adjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2991385-5

7 January 2021

Disease-free survival at intervals during and following completion of adjuvant chemotherapy: the NSABP experience from three breast cancer protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2991385-5

7 January 2021

Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2991385-5

7 January 2021

10.1016/S0140-6736(83)91385-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6132179%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference